113 related articles for article (PubMed ID: 15506450)
1. [Calcium channel blockers increasing coronary blood flow via NO-dependent mechanism].
Asanuma H; Kitakaze M
Nihon Rinsho; 2004 Sep; 62 Suppl 9():567-72. PubMed ID: 15506450
[No Abstract] [Full Text] [Related]
2. [Enhancement of NO bioavailability by ACEI and ARB].
Fukuo K
Nihon Rinsho; 2004 Sep; 62 Suppl 9():561-6. PubMed ID: 15506449
[No Abstract] [Full Text] [Related]
3. [NO and atherosclerosis].
Ohtani K; Egashira K
Nihon Rinsho; 2004 Sep; 62 Suppl 9():544-7. PubMed ID: 15506446
[No Abstract] [Full Text] [Related]
4. L-type Ca2+ channels are not involved in coronary endothelial Ca2+ influx mechanism responsible for endothelium-dependent relaxation.
Uchida H; Tanaka Y; Ishii K; Nakayama K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):127-44. PubMed ID: 10634306
[TBL] [Abstract][Full Text] [Related]
5. Role of nitric oxide during coronary endothelial dysfunction after myocardial infarction.
Berges A; Van Nassauw L; Timmermans JP; Vrints C
Eur J Pharmacol; 2005 May; 516(1):60-70. PubMed ID: 15923002
[TBL] [Abstract][Full Text] [Related]
6. Amlodipine releases nitric oxide from canine coronary microvessels: An unexpected mechanism of action of a calcium channel-blocking agent.
Dhein S; Salameh A
Circulation; 1999 Aug; 100(9):1011. PubMed ID: 10468534
[No Abstract] [Full Text] [Related]
7. Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.
Vaziri ND; Ding Y; Ni Z; Barton CH
J Pharmacol Exp Ther; 2005 Apr; 313(1):121-6. PubMed ID: 15640399
[TBL] [Abstract][Full Text] [Related]
8. [Calcium antagonists: current and future applications based on new evidence. Pleiotropic effects of calcium channel blockers on vascular endothelial function].
Morimoto Y; Kureishi-Bando Y; Murohara T
Clin Calcium; 2010 Jan; 20(1):69-75. PubMed ID: 20048436
[TBL] [Abstract][Full Text] [Related]
9. The paradox of nitric oxide in cirrhosis and portal hypertension: too much, not enough.
Wiest R; Groszmann RJ
Hepatology; 2002 Feb; 35(2):478-91. PubMed ID: 11826425
[No Abstract] [Full Text] [Related]
10. [Inhibition of VSMC proliferation by nitric oxide].
Sato R; Hirata Y
Nihon Rinsho; 2004 Sep; 62 Suppl 9():496-9. PubMed ID: 15506435
[No Abstract] [Full Text] [Related]
11. Endothelium, atherosclerosis and calcium channel blockers.
Biswas TK
J Indian Med Assoc; 2003 Jul; 101(7):428-31. PubMed ID: 14748381
[TBL] [Abstract][Full Text] [Related]
12. [Cerebroprotection with calcium channel blockers].
Mogi M; Iwai M; Horiuchi M
Nihon Rinsho; 2006 Jul; 64 Suppl 5():531-5. PubMed ID: 16895222
[No Abstract] [Full Text] [Related]
13. Differences in nitric oxide production in porcine resistance arteries and epicardial conduit coronary arteries.
Xu XP; Liu Y; Tanner MA; Sturek M; Myers PR
J Cell Physiol; 1996 Sep; 168(3):539-48. PubMed ID: 8816908
[TBL] [Abstract][Full Text] [Related]
14. The calcium channel blocker amlodipine promotes the unclamping of eNOS from caveolin in endothelial cells.
Batova S; DeWever J; Godfraind T; Balligand JL; Dessy C; Feron O
Cardiovasc Res; 2006 Aug; 71(3):478-85. PubMed ID: 16814758
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for arsenic-induced alteration in nitric oxide production and oxidative stress: implication of endothelial dysfunction.
Kumagai Y; Pi J
Toxicol Appl Pharmacol; 2004 Aug; 198(3):450-7. PubMed ID: 15276426
[TBL] [Abstract][Full Text] [Related]
16. [The influence of coronary flow on atrio-ventricular transmission and ventricular contraction in the isolated guinea pig heart].
Torres JC; Pastelín G; Suárez J
Arch Inst Cardiol Mex; 1999; 69(5):403-10. PubMed ID: 10640203
[TBL] [Abstract][Full Text] [Related]
17. A calcium channel blocker amlodipine increases coronary blood flow via both adenosine- and NO-dependent mechanisms in ischemic hearts.
Asanuma H; Minamino T; Sanada S; Ogita H; Kim J; Fujita M; Hirata A; Tsukamoto O; Ogai A; Node K; Hori M; Tomoike H; Kitakaze M
J Mol Cell Cardiol; 2005 Oct; 39(4):605-14. PubMed ID: 16087189
[TBL] [Abstract][Full Text] [Related]
18. Dysfunction of endothelial nitric oxide synthase and atherosclerosis.
Kawashima S; Yokoyama M
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):998-1005. PubMed ID: 15001455
[TBL] [Abstract][Full Text] [Related]
19. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
[TBL] [Abstract][Full Text] [Related]
20. Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes.
Bai CX; Namekata I; Kurokawa J; Tanaka H; Shigenobu K; Furukawa T
Circ Res; 2005 Jan; 96(1):64-72. PubMed ID: 15569827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
